+Search query
-Structure paper
Title | PD-1 N58-Glycosylation-Dependent Binding of Monoclonal Antibody Cemiplimab for Immune Checkpoint Therapy. |
---|---|
Journal, issue, pages | Front Immunol, Vol. 13, Page 826045-826045, Year 2022 |
Publish date | Feb 10, 2022 (structure data deposition date) |
Authors | Lu, D. / Xu, Z. / Zhang, D. / Jiang, M. / Liu, K. / He, J. / Ma, D. / Ma, X. / Tan, S. / Gao, G.F. / Chai, Y. |
External links | Front Immunol / PubMed:35309324 |
Methods | X-ray diffraction |
Resolution | 3.4 Å |
Structure data | PDB-7wvm: |
Source |
|
Keywords | IMMUNE SYSTEM/ANTITUMOR PROTEIN / PD-1 / antibody / N58 glycosylation / cemiplimab / immune checkpoint therapy (ICT) / ANTITUMOR PROTEIN / IMMUNE SYSTEM-ANTITUMOR PROTEIN complex |